Back to Search
Start Over
P553: PRELIMINARY RESULTS OF MRD ANALYSIS OF AML1718, A PHASE 2 OPEN-LABEL STUDY OF VENETOCLAX, FLUDARABINE, IDARUBICIN AND CYTARABINE (V-FLAI) IN THE INDUCTION THERAPY OF NON LOW-RISK AML.
- Source :
- HemaSphere; 2023 Supplement 3, Vol. 7, pe997112b-e997112b, 1p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 25729241
- Volume :
- 7
- Database :
- Complementary Index
- Journal :
- HemaSphere
- Publication Type :
- Academic Journal
- Accession number :
- 169965977
- Full Text :
- https://doi.org/10.1097/01.HS9.0000969120.99711.2b